Raras
Buscar doenças, sintomas, genes...
Doença Menkes
ORPHA:565CID-10 · E83.0CID-11 · 5C64.0YOMIM 309400DOENÇA RARA

Uma doença geralmente grave que afeta vários sistemas do corpo, causada por um problema no metabolismo do cobre. Caracteriza-se pela degeneração progressiva das células nervosas, por alterações importantes nos tecidos que dão suporte ao organismo (como pele, ossos e vasos sanguíneos), além de cabelos ralos, com aspecto incomum e uma textura que lembra aço.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Uma doença geralmente grave que afeta vários sistemas do corpo, causada por um problema no metabolismo do cobre. Caracteriza-se pela degeneração progressiva das células nervosas, por alterações importantes nos tecidos que dão suporte ao organismo (como pele, ossos e vasos sanguíneos), além de cabelos ralos, com aspecto incomum e uma textura que lembra aço.

Pesquisas ativas
3 ensaios
9 total registrados no ClinicalTrials.gov
Publicações científicas
893 artigos
Último publicado: 2026 Mar 23

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Início
Neonatal
🏥
SUS: Cobertura mínimaScore: 15%
CID-10: E83.0
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (2)
0202010538
Dosagem de ceruloplasmina (Wilson)lab_test
0202010562
Dosagem de cobre sérico
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧬
Pele e cabelo
10 sintomas
🦴
Ossos e articulações
9 sintomas
🧠
Neurológico
9 sintomas
🫃
Digestivo
5 sintomas
📏
Crescimento
3 sintomas
👁️
Olhos
2 sintomas

+ 29 sintomas em outras categorias

Características mais comuns

100%prev.
Início na infância
Obrigatório (100%)
100%prev.
Alopecia
Obrigatório (100%)
100%prev.
Sinal de Babinski
Obrigatório (100%)
100%prev.
Cabelo quebradiço
Obrigatório (100%)
100%prev.
Concentração diminuída de ceruloplasmina circulante
Obrigatório (100%)
100%prev.
Espasmo epiléptico
Obrigatório (100%)
73sintomas
Muito frequente (31)
Frequente (19)
Ocasional (14)
Sem dados (9)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 73 características clínicas mais associadas, ordenadas por frequência.

Início na infânciaInfantile onset
Obrigatório (100%)100%
Alopecia
Obrigatório (100%)100%
Sinal de BabinskiBabinski sign
Obrigatório (100%)100%
Cabelo quebradiçoBrittle hair
Obrigatório (100%)100%
Concentração diminuída de ceruloplasmina circulanteDecreased circulating ceruloplasmin concentration
Obrigatório (100%)100%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico893PubMed
Últimos 10 anos200publicações
Pico201925 papers
Linha do tempo
2026Hoje · 2026🧪 1990Primeiro ensaio clínico📈 2019Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição. Padrão de herança: X-linked recessive.

ATP7ACopper-transporting ATPase 1Disease-causing germline mutation(s) (loss of function) inAltamente restrito
FUNÇÃO

ATP-driven copper (Cu(+)) ion pump that plays an important role in intracellular copper ion homeostasis (PubMed:10419525, PubMed:11092760, PubMed:28389643). Within a catalytic cycle, acquires Cu(+) ion from donor protein on the cytoplasmic side of the membrane and delivers it to acceptor protein on the lumenal side. The transfer of Cu(+) ion across the membrane is coupled to ATP hydrolysis and is associated with a transient phosphorylation that shifts the pump conformation from inward-facing to

LOCALIZAÇÃO

Golgi apparatus, trans-Golgi network membraneCell membraneMelanosome membraneEarly endosome membraneCell projection, axonCell projection, dendritePostsynaptic densityCytoplasm, cytosolEndoplasmic reticulum

VIAS BIOLÓGICAS (1)
Detoxification of Reactive Oxygen Species
MECANISMO DE DOENÇA

Menkes disease

An X-linked recessive disorder of copper metabolism characterized by generalized copper deficiency. MNKD results in progressive neurodegeneration and connective-tissue disturbances: focal cerebral and cerebellar degeneration, early growth retardation, peculiar hair, hypopigmentation, cutis laxa, vascular complications and death in early childhood. The clinical features result from the dysfunction of several copper-dependent enzymes. A mild form of the disease has been described, in which cerebellar ataxia and moderate developmental delay predominate.

OUTRAS DOENÇAS (4)
occipital horn syndromeX-linked distal spinal muscular atrophy type 3Menkes diseaseHirschsprung disease
HGNC:869UniProt:Q04656

Medicamentos aprovados (FDA)

1 medicamento encontrado nos registros da FDA americana.

💊 Zycubo (COPPER HISTIDINATE)
Ver no DailyMed/FDA

Variantes genéticas (ClinVar)

604 variantes patogênicas registradas no ClinVar.

🧬 ATP7A: NM_000052.7(ATP7A):c.886G>T (p.Glu296Ter) ()
🧬 ATP7A: NM_000052.7(ATP7A):c.2335_2339del (p.Thr779fs) ()
🧬 ATP7A: NM_000052.7(ATP7A):c.3188C>G (p.Thr1063Ser) ()
🧬 ATP7A: GRCh37/hg19 Xq13.1-22.2(chrX:70460290-103312921)x3 ()
🧬 ATP7A: NM_000052.7(ATP7A):c.1711A>T (p.Arg571Trp) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 2 variantes classificadas pelo ClinVar.

2
Patogênica (100.0%)
VARIANTES MAIS SIGNIFICATIVAS
ATP7A: NM_000052.7(ATP7A):c.1947-3_1948dup [Conflicting classifications of pathogenicity]
ATP7A: NM_000052.7(ATP7A):c.4123+3A>T [Conflicting classifications of pathogenicity]

Vias biológicas (Reactome)

3 vias biológicas associadas aos genes desta condição.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
3Fase 31
2Fase 22
·Pré-clínico4
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 7 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Doença Menkes

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

2 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

9 ensaios clínicos encontrados, 3 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

🥇Melhor nível de evidência: Revisão sistemática
Timeline de publicações
244 papers (10 anos)
#1

Zycubo (copper histidinate), the first treatment for pediatric Menkes disease.

Trends in pharmacological sciences2026 Mar 11

Copper histidinate (marketed as ZYCUVO®, formerly known as CUTX-101) is a copper replacement product indicated for the treatment of Menkes disease in pediatric patients. The chemical name is copper, (L-histidinato-κN,κN3,κO)(L-histidinato-κN,κO)-, (SP-5–14-C)- or copper bis((2S)-2-amino-3-(1H-imidazol-5-yl)propanoate). Copper histidinate has a molecular formula of C12H16CuN6O4 and a molecular weight of 371.84 g/mol. The molecule consists of a central copper (II) ion coordinated by two L-histidine ligands through nitrogen and oxygen donor atoms, forming a stable chelated complex that facilitates systemic copper delivery following subcutaneous administration. Copper histidinate is fully soluble in water, forming a blue solution. Reconstituted solutions must be used within 4 hours at room temperature (20°C to 25°C) or within 24 hours if refrigerated (2°C to 8°C). [Image: see text]

#2

Research Progress on Copper Metabolism, Cuprotosis, and Their Regulatory Mechanism in Tumor Diagnosis and Treatment.

Cancer management and research2026

A co-factor of multiple metalloenzymes that promote normal physiological functions, such as the immune system, neurological system, human hematological function, bone health, and antioxidant action, copper is one of the most important trace metals in the human body. The copper content in the human body maintains a relatively constant level; too much copper can cause Wilson's disease, and too little can cause Menkes disease. Copper is involved in the physiological functions of many body systems and has a very complex transport system with many transporters. In order to offer fresh concepts and a theoretical foundation for cancer treatment, this article will go into great detail about the distinct metabolic pathways of copper and the function of cell death, particularly the function of copper-controlled cell death, especially cuproptosis, in cancer detection and treatment. Cuproptosis, a copper-dependent cell death distinct from necrosis, apoptosis, and ferroptosis, is triggered by excessive intracellular copper binding to lipoylated tricarboxylic acid (TCA) cycle proteins, leading to abnormal protein aggregation and loss of iron-sulfur clusters in respiratory chain complexes. Future research may focus on optimizing the specificity of copper metabolism-related biomarkers (eg, CTR1, SOD1) for early tumor screening, developing targeted copper ionophores/chelators with low systemic toxicity, and exploring the crosstalk between copper metabolism and tumor immunity to establish multi-dimensional diagnosis and treatment strategies.

#3

Copper Homeostasis and Cuproptosis in Neurological Disorders.

Drug design, development and therapy2026

Neurological disorders such as Alzheimer's disease (AD) and Parkinson's disease (PD) pose a serious global public health threat, with complex etiologies involving genetic, environmental, and metabolic factors. Current data indicate that the prevalence of these disorders is rapidly increasing with the aging population, resulting in a growing economic and healthcare burden worldwide. In recent years, the imbalance of copper homeostasis has been increasingly implicated in the pathogenesis of neurological diseases. Copper overload can aggravate neuronal injury by inducing oxidative stress (OS), mitochondrial dysfunction, and protein misfolding, while copper deficiency disrupts the function of copper-dependent enzymes and leads to metabolic abnormalities. The mechanism of cuproptosis, proposed in 2022, describes a novel form of programmed cell death characterized by lipoylated protein aggregation and the loss of Fe-S cluster proteins, offering new insights into copper-related diseases. Multiple studies have demonstrated the crucial role of copper homeostasis and cuproptosis in the onset, progression, and treatment of neurological diseases. This narrative review summarizes the molecular mechanisms involved in copper homeostasis regulation and, on that basis, discusses the role of copper metabolism abnormalities in AD, PD, Huntington's disease (HD), amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), Wilson's disease (WD), Menkes disease (MD), and stroke. Additionally, we highlight the mechanisms of existing copper-regulating drugs and their therapeutic potential in neurological disorders, while pointing out the limitations of current drug development. Copper homeostasis imbalance plays a critical regulatory role in neurological disorders.Cuproptosis is a unique form of copper-mediated cell death that plays a key role in neuronal injury.Many key questions regarding the differences in copper homeostasis and cuproptosis mechanisms among various neurological disorders remain unresolved.The interplay between copper and other metal ions (such as iron and zinc) in maintaining homeostasis may have important implications in neurological disorders.

#4

Patient Burden in the Treatment of Wilson Disease in the United States: An Analysis of Real-World Health Insurance Claims Data from the Komodo database.

Advances in therapy2026 Feb 20

Wilson disease (WD) is a rare inherited disorder that causes copper accumulation and can be fatal if untreated. This study used real-world data from the US Komodo Health claims database to describe healthcare resource utilization (HCRU) and evaluate direct economic costs among patients with WD. This retrospective observational study identified patients with WD using ICD-9/10 codes (excluding Menkes disease) between 2016 and 2019, with data spanning 2012-2020. Sociodemographic characteristics, HCRU, and costs were analyzed using SPSS v23, SAS v9.4, and R v3.6.0. The study was approved by Pearl Pathways IRB (#20-KANT-224). A total of 2115 patients with prevalent WD, including 360 ever-treated (with reimbursable WD prescriptions), were identified. During the 2-year follow-up, about 25% were hospitalized, with a mean stay of 9 days, and most visited the ER three times annually. Hepatic patients with WD were more likely to undergo liver biopsy or transplant but had fewer home health visits and less use of assistive mobility devices. Annual liver transplant costs averaged $9094.72 ± 8110.23 per prevalent WD patient and $10,147.98 ± 7030.83 per ever-treated patient. Mean annual costs per prevalent versus ever-treated patients with WD were inpatient ($716.52 ± 2675.06 vs. $252.75 ± 333.39), pharmacy ($270.35 ± 1348.79 vs. $1284.51 ± 2994.85), and outpatient ($73.93 ± 156.89 vs. $60.82 ± 62.17), respectively. Pharmacy costs for adherent patients averaged $157,505.28 for any medication, $252,617.11 for D-penicillamine, $189,328.52 for trientine, and $1574.91 for zinc. Among ever-treated patients with WD, respective costs were lower at $85,117.60, $123,190.73, $100,017.20, and $820.35. Estimated annual HCRU and treatment costs for patients with WD were lower than previously reported. These findings provide updated real-world insights into the economic burden of WD and highlight the cost implications of medication adherence in managing this rare disorder in the USA.

#5

Whole genome sequencing from dried blood spots for newborn screening of Menkes disease and 36 other actionable inherited neurometabolic disorders.

Molecular genetics and metabolism2026 Mar

Tandem mass spectrometry is currently used by the Ohio Department of Health to screen newborn infants for 36 medically actionable inborn errors of metabolism. As a complementary test for infants with abnormal biochemical screens, whole genome sequencing (WGS) theoretically could reduce false-positive results, facilitate timely case resolution and, in some instances, indicate a more specific diagnosis than obtained initially. Menkes disease is a X-linked recessive disorder of human copper metabolism with a predicted minimum birth prevalence of 1 in 34,810 live male births. Recent progress in treatment options for Menkes heighten the importance of newborn screening (NBS) to identify this illness within the window of therapeutic opportunity, the first 4 to 6 weeks of life. We developed a DNA extraction protocol from dried blood spots that yielded high quality DNA for whole genome sequencing and studied 24 subjects with known ATP7A variants. Analysis was confined to genes (n = 55) for neurometabolic conditions currently screened for in Ohio (n = 36) plus ATP7A (Menkes disease). WGS detected all ATP7A variants including 7 missense, 5 splice site, 4 copy number variants, 4 nonsense, 3 indels, and 1 missense/splice site. WGS also detected 5 heterozygous pathogenic variants in 5 genes that encode conditions for which Ohio screens. Our results confirm the feasibility and reliability of this approach for early Menkes disease detection and to complement tandem mass spectroscopy for detection of other actionable inherited disorders.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC480 artigos no totalmostrando 196

2026

Menkes Disease: Another Example of Progress in the Development of Pharmaceuticals for Rare Childhood Diseases, But Much Still Remains to Be Done.

Clinical therapeutics
2026

Research Progress on Copper Metabolism, Cuprotosis, and Their Regulatory Mechanism in Tumor Diagnosis and Treatment.

Cancer management and research
2026

Zycubo (copper histidinate), the first treatment for pediatric Menkes disease.

Trends in pharmacological sciences
2026

Copper Homeostasis and Cuproptosis in Neurological Disorders.

Drug design, development and therapy
2026

Patient Burden in the Treatment of Wilson Disease in the United States: An Analysis of Real-World Health Insurance Claims Data from the Komodo database.

Advances in therapy
2026

Concerns regarding the safety and efficacy of ES-Cu-Captisol for Menkes disease. Reply.

The Journal of clinical investigation
2026

Concerns regarding the safety and efficacy of ES-Cu-Captisol for Menkes disease.

The Journal of clinical investigation
2026

Whole genome sequencing from dried blood spots for newborn screening of Menkes disease and 36 other actionable inherited neurometabolic disorders.

Molecular genetics and metabolism
2026

Distinct signaling mechanisms and proteome phenotypes are elicited by compartment-specific genetic defects of copper homeostasis.

bioRxiv : the preprint server for biology
2026

NON-REDUNDANT ROLES OF COPPER TRANSPORTERS ATP7A AND ATP7B IN NORADRENERGIC SIGNALING.

bioRxiv : the preprint server for biology
2026

Deciphering Copper Homeostasis and Cuproptosis: Biological Mechanisms, Disease Connections, and Cutting-Edge Copper-Based Nanomedicine.

Molecular pharmaceutics
2026

CRISPR prime editing as a promising therapeutic avenue for Menkes disease: the next step in correcting ATP7A mutations.

Annals of medicine and surgery (2012)
2026

Role of cuproptosis in digestive system tumors (Review).

International journal of molecular medicine
2025

Retropseudogene insertion generated through retrotransposition in the ATP7A gene results in premature stop codons and a case of Menkes disease.

Frontiers in neurology
2025

Early-onset urinary calculi in Menkes disease: A rare presentation in a 5-month-old infant.

Pediatrics international : official journal of the Japan Pediatric Society
2025

Elesclomol-Mediated Alterations of Liver Metabolism in the Context of Mouse Mblac1 Disruption.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
2026

Copper in Human Health and Disease: Insights from Inherited Disorders.

Physiology (Bethesda, Md.)
2025

Copper homeostasis and cuproptosis: implications for neurodegenerative diseases.

Frontiers in aging neuroscience
2025

Novel ATP7A Splice-Site Variant Causing Distal Motor Neuropathy and Occipital Horn Syndrome: Two Siblings and Literature Review.

Genes
2026

Interference-free SERS tags for copper ion sensing upon hypoxia by in situ hot-spot generation.

Talanta
2025

Intravenous AAV9-ATP7A plus subcutaneous copper histidinate optimizes outcomes in a lethal Menkes disease mouse model.

Science advances
2025

Elesclomol-copper therapy improves neurodevelopment in two children with Menkes disease.

The Journal of clinical investigation
2025

Alpha-synuclein null mutation exacerbates the phenotype of a model of Menkes disease in female mice.

Frontiers in neuroscience
2025

Atp7a deficiency induces axonal and myelin developmental defects in zebrafish via ferroptosis.

Neurobiology of disease
2025

Severe Shock Caused by Rupture of Bladder Diverticulum in a Patient With Menkes Disease: A Case Report.

Clinical case reports
2025

Overcoming barriers in Menkes disease: A standardized high quality and stable injectable copper histidinate.

Journal of pharmaceutical sciences
2025

Elesclomol rescues mitochondrial copper deficiency in disease models without triggering cuproptosis.

The Journal of pharmacology and experimental therapeutics
2025

Menkes disease with unilateral lacrimal fistula.

Journal francais d'ophtalmologie
2025

Identification of a Novel ATP7A Variant in a Chinese Boy With Developmental Delay and Epilepsy.

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience
2025

Restoration of Genetic Code in Macular Mouse Fibroblasts via APOBEC1-Mediated RNA Editing.

Biomolecules
2025

Copper homeostasis and pregnancy complications: a comprehensive review.

Journal of assisted reproduction and genetics
2024

Two Cases of Menkes Disease With Similar Intracranial Arterial Tortuosity on Brain Magnetic Resonance Imaging.

Cureus
2025

Copper homeostasis and neurodegenerative diseases.

Neural regeneration research
2024

Case Report: A male newborn with occipital horn syndrome.

F1000Research
2024

Copper and Colorectal Cancer.

Cancers
2024

Novel, likely pathogenic variant in ATP7A associated with Menkes disease diagnosed with ultrarapid genome sequencing.

BMJ case reports
2024

[Epilepsy and inborn errors of metabolism].

Revista de neurologia
2025

Mammalian copper homeostasis: physiological roles and molecular mechanisms.

Physiological reviews
2024

Focus on cuproptosis: Exploring new mechanisms and therapeutic application prospects of cuproptosis regulation.

Biomedicine &amp; pharmacotherapy = Biomedecine &amp; pharmacotherapie
2025

Role of copper in central nervous system physiology and pathology.

Neural regeneration research
2025

Phenotypic and mutational spectrum of 17 Chinese patients with Menkes Disease.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2024

[Research progress on regulatory mechanism of renal copper homeostasis].

Sheng li xue bao : [Acta physiologica Sinica]
2024

Brain and the whole-body bone imaging appearances in Menkes disease: a case report and literature review.

BMC pediatrics
2024

Unraveling Copper Exchange in the Atox1-Cu(I)-Mnk1 Heterodimer: A Simulation Approach.

The journal of physical chemistry. B
2024

The physiological and pathophysiological roles of copper in the nervous system.

The European journal of neuroscience
2024

Synthesis and Biological Activities of Some Metal Complexes of Peptides: A Review.

Biotech (Basel (Switzerland))
2024

Mechanism of Cu entry into the brain: many unanswered questions.

Neural regeneration research
2024

Preimplantation genetic testing for monogenic disorders (PGT-M) offers an alternative strategy to prevent children from being born with hereditary neurological diseases or metabolic diseases dominated by nervous system phenotypes: a retrospective study.

Journal of assisted reproduction and genetics
2024

Cuproptosis: Unraveling the Mechanisms of Copper-Induced Cell Death and Its Implication in Cancer Therapy.

Cancers
2024

Disorders of Copper Metabolism in Children-A Problem too Rarely Recognized.

Metabolites
2024

Copper release by MOF-74(Cu): a novel pharmacological alternative to diseases with deficiency of a vital oligoelement.

RSC advances
2024

Unfavorable switching of skewed X chromosome inactivation leads to Menkes disease in a female infant.

Scientific reports
2024

Deep intronic variant causes aberrant splicing of ATP7A in a family with a variable occipital horn syndrome phenotype.

European journal of medical genetics
2024

Insights Into the Role of Copper in Neurodegenerative Diseases and the Therapeutic Potential of Natural Compounds.

Current neuropharmacology
2023

[Analysis of clinical characteristics and ATP7A gene variants in a Chinese pedigree affected with Menkes disease].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2023

Massive thrombosis in internal jugular phlebectasia in Menkes disease.

Pediatrics international : official journal of the Japan Pediatric Society
2024

The Tao of Copper Metabolism: From Physiology to Pathology.

Current medicinal chemistry
2023

Current and Future of "Turn-On" Based Small-Molecule Copper Probes for Cuproptosis.

ChemistryOpen
2023

LAT1 (SLC7A5) catalyzes copper(histidinate) transport switching from antiport to uniport mechanism.

iScience
2023

Copper-transporting ATPases throughout the animal evolution - From clinics to basal neuron-less animals.

Gene
2023

An ESIPT solvatochromic fluorescent and colorimetric probe for sensitive and selective detection of copper ions in environmental samples and cell lines.

The Analyst
2024

Genetic etiology of progressive pediatric neurological disorders.

Pediatric research
2023

Bioactive copper(II) agents and their potential involvement in the treatment of copper deficiency-related orphan diseases.

Journal of inorganic biochemistry
2023

The 100 top-cited articles in the field of Wilson's disease from 1990 to 2022: A bibliometric study.

Heliyon
2023

Integrating reduced amino acid composition into PSSM for improving copper ion-binding protein prediction.

International journal of biological macromolecules
2023

[Clinical and genetic analysis of three children with Menkes disease due to variants of ATP7A gene].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2023

Regulatory roles of copper metabolism and cuproptosis in human cancers.

Frontiers in oncology
2023

Ethics in pre-ART genetics: a missed X-linked Menkes disease case.

Journal of assisted reproduction and genetics
2023

Menkes disease complicated by concurrent ACY1 deficiency: A case report.

Frontiers in genetics
2023

Health-Related Quality of Life and Family Functioning of Primary Caregivers of Children with Menkes Disease.

Journal of clinical medicine
2023

FDX1-dependent and independent mechanisms of elesclomol-mediated intracellular copper delivery.

Proceedings of the National Academy of Sciences of the United States of America
2023

Copper homeostasis and the ubiquitin proteasome system.

Metallomics : integrated biometal science
2023

ATP7A-related copper transport disorders: A systematic review and definition of the clinical subtypes.

Journal of inherited metabolic disease
2023

Atp7b-dependent choroid plexus dysfunction causes transient copper deficit and metabolic changes in the developing mouse brain.

PLoS genetics
2022

Evaluation of hair structural abnormalities in children with different neurological diseases.

The Turkish journal of pediatrics
2023

Fatal congenital copper transport defect caused by a homozygous likely pathogenic variant of SLC31A1.

Clinical genetics
2022

Heterogeneous nuclear ribonucleoprotein hnRNPA2/B1 regulates the abundance of the copper-transporter ATP7A in an isoform-dependent manner.

Frontiers in molecular biosciences
2023

Mitochondrial copper in human genetic disorders.

Trends in endocrinology and metabolism: TEM
2022

Decreased Expression of the Slc31a1 Gene and Cytoplasmic Relocalization of Membrane CTR1 Protein in Renal Epithelial Cells: A Potent Protective Mechanism against Copper Nephrotoxicity in a Mouse Model of Menkes Disease.

International journal of molecular sciences
2022

Newly identified disorder of copper metabolism caused by variants in CTR1, a high-affinity copper transporter.

Human molecular genetics
2022

Elesclomol elevates cellular and mitochondrial iron levels by delivering copper to the iron import machinery.

The Journal of biological chemistry
2022

Almost misdiagnosed Menkes disease: A case report.

Heliyon
2022

Oral Elesclomol Treatment Alleviates Copper Deficiency in Animal Models.

Frontiers in cell and developmental biology
2022

Identification of a Novel Deep Intronic Variant by Whole Genome Sequencing Combined With RNA Sequencing in a Chinese Patient With Menkes Disease.

Frontiers in genetics
2022

Copper-histidine therapy in an infant with novel splice-site variant in the ATP7A gene of Menkes disease: the first experience in South East Asia and literature review.

BMJ case reports
2022

Critical Points in the Methodology of Preparing Copper (II) Histidinate Injections and their Quality Assessment Applying Color Measurement.

Journal of pharmaceutical sciences
2022

Early clinical signs and treatment of Menkes disease.

Molecular genetics and metabolism reports
2022

Abnormal Development of Neural Stem Cell Niche in the Dentate Gyrus of Menkes Disease.

International journal of stem cells
2022

Menkes Disease: Clinical Presentation and Imaging Characteristics.

Neuropediatrics
2022

Usefulness of Trichoscopy over Hair Light Microscopy in Menkes Disease.

Skin appendage disorders
2021

Hair microscopy: an easy adjunct to diagnosis of systemic diseases in children.

Applied microscopy
2021

Tracking Labile Copper Fluctuation In Vivo/Ex Vivo: Design and Application of a Ratiometric Near-Infrared Fluorophore Derived from 4-Aminostyrene-Conjugated Boron Dipyrromethene.

Inorganic chemistry
2021

Seizures of unknown etiology associated with brittle hair: A diagnostic challenge.

JAAD case reports
2021

Pili Torti: A Feature of Numerous Congenital and Acquired Conditions.

Journal of clinical medicine
2021

Tubular Dysfunction and Ruptured Ureter in a Child with Menkes Syndrome.

Case reports in pediatrics
2021

Menkes disease diagnosed by a novel ATP7A frameshift mutation in a patient with infantile spasms-a case report.

Translational pediatrics
2021

Pharmacokinetics of CuGTSM, a Novel Drug Candidate, in a Mouse Model of Menkes Disease.

Pharmaceutical research
2021

The molecular and cellular basis of copper dysregulation and its relationship with human pathologies.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
2023

Therapeutic Use of Trace Elements in Dermatology.

Alternative therapies in health and medicine
2021

Copper nutrition and biochemistry and human (patho)physiology.

Advances in food and nutrition research
2021

Whole-Exome Sequencing, Proteome Landscape, and Immune Cell Migration Patterns in a Clinical Context of Menkes Disease.

Genes
2021

Neuropathological findings in a 17-month-old boy with kinky hair due to Menkes disease.

Clinical neuropathology
2021

Genetic causes of fractures and subdural hematomas: fact versus fiction.

Pediatric radiology
2021

Occipital Horn Syndrome as a Result of Splice Site Mutations in ATP7A. No Activity of ATP7A Splice Variants Missing Exon 10 or Exon 15.

Frontiers in molecular neuroscience
2021

ATP7A-Regulated Enzyme Metalation and Trafficking in the Menkes Disease Puzzle.

Biomedicines
2021

Hair Abnormalities: Key to Suspecting Menkes Disease.

Actas dermo-sifiliograficas
2021

Copper Toxicity Associated With an ATP7A-Related Complex Phenotype.

Pediatric neurology
2021

[Pedigree study and analysis of ATP7A gene variants in three children with Menkes disease].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2021

Antioxidant vs. Prooxidant Properties of the Flavonoid, Kaempferol, in the Presence of Cu(II) Ions: A ROS-Scavenging Activity, Fenton Reaction and DNA Damage Study.

International journal of molecular sciences
2021

COMMD1, a multi-potent intracellular protein involved in copper homeostasis, protein trafficking, inflammation, and cancer.

Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS)
2021

The M1311V variant of ATP7A is associated with impaired trafficking and copper homeostasis in models of motor neuron disease.

Neurobiology of disease
2022

Inborn Errors of Metabolism in a Tertiary Pediatric Intensive Care Unit.

Journal of pediatric intensive care
2020

Copper Dyshomeostasis in Neurodegenerative Diseases-Therapeutic Implications.

International journal of molecular sciences
2022

Effect of homeostatic iron regulator protein gene mutation on Wilson's disease clinical manifestation: original data and literature review.

The International journal of neuroscience
2020

Investigation of Genetic Modifiers of Copper Toxicosis in Labrador Retrievers.

Life (Basel, Switzerland)
2020

ATP7A mutation with occipital horns and distal motor neuropathy: A continuum.

European journal of medical genetics
2021

Repurposing elesclomol, an investigational drug for the treatment of copper metabolism disorders.

Expert opinion on investigational drugs
2020

ATP7A Clinical Genetics Resource - A comprehensive clinically annotated database and resource for genetic variants in ATP7A gene.

Computational and structural biotechnology journal
2021

Laparoscopic patch repair of a Morgagni hernia in Menkes disease.

Asian journal of endoscopic surgery
2020

LC-ICP-MS method for the determination of "extractable copper" in serum.

Metallomics : integrated biometal science
2020

Wilson's Disease: Diagnosis of Wilson's Disease in Ethiopian Young Sisters.

Case reports in medicine
2020

Targeted next generation sequencing for newborn screening of Menkes disease.

Molecular genetics and metabolism reports
2020

[Menkes disease, a diagnosis to consider in case of severe epilepsy with hyperlactacidemia: a case report].

Annales de biologie clinique
2020

Cancer Pro-oxidant Therapy Through Copper Redox Cycling: Repurposing Disulfiram and Tetrathiomolybdate.

Current pharmaceutical design
2020

Low function of natural killer cells in treated classic Menkes disease.

The Turkish journal of pediatrics
2020

Estimated birth prevalence of Menkes disease and ATP7A-related disorders based on the Genome Aggregation Database (gnomAD).

Molecular genetics and metabolism reports
2020

Zinc Monotherapy as an Alternative Treatment Option for Decompensated Liver Disease due to Wilson Disease?

Case reports in hepatology
2020

The molecular mechanisms of copper metabolism and its roles in human diseases.

Pflugers Archiv : European journal of physiology
2021

Visual Dermatology: Menkes Disease.

Journal of cutaneous medicine and surgery
2020

An Unusual Presentation of Menkes Disease Masquerading as a Leukodystrophy with Macrocephaly.

Journal of pediatric neurosciences
2020

Rare Genetic Diseases: Nature's Experiments on Human Development.

iScience
2020

Elesclomol alleviates Menkes pathology and mortality by escorting Cu to cuproenzymes in mice.

Science (New York, N.Y.)
2020

Neck masses due to internal jugular vein phlebectasia: Frequency in Menkes disease and literature review of 85 pediatric subjects.

American journal of medical genetics. Part A
2020

Functional analyses of copper transporter genes in the human liver cell line HepG2.

Toxicology in vitro : an international journal published in association with BIBRA
2020

[Genetic analysis of a male infant with Menkes disease].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2019

Reduced Neutrophil Extracellular Trap (NET) Formation During Systemic Inflammation in Mice With Menkes Disease and Wilson Disease: Copper Requirement for NET Release.

Frontiers in immunology
2020

Osseous Metaplasia in a Bladder Diverticulum in a Patient with Mosaic Menkes Disease.

Urology
2019

Copper and the brain noradrenergic system.

Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry
2019

Homozygous Loss-of-Function Mutations in AP1B1, Encoding Beta-1 Subunit of Adaptor-Related Protein Complex 1, Cause MEDNIK-like Syndrome.

American journal of human genetics
2019

Report of a novel ATP7A mutation causing distal motor neuropathy.

Neuromuscular disorders : NMD
2019

Wormian Bones and Dilated Scalp Veins in an Infant With Epilepsy.

Journal of pediatric neurosciences
2019

Animal Models of Normal and Disturbed Iron and Copper Metabolism.

The Journal of nutrition
2019

Adipocyte-specific disruption of ATPase copper transporting α in mice accelerates lipoatrophy.

Diabetologia
2019

A severe case of Menkes disease with repeated bone fracture during the neonatal period, followed by multiple arterial occlusion.

Brain &amp; development
2019

Menkes disease complicated by concurrent Koolen-de Vries syndrome (17q21.31 deletion).

Molecular genetics &amp; genomic medicine
2019

Copper Deficiency: Causes, Manifestations, and Treatment.

Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition
2019

Imaging findings of Menkes disease, a radiographic mimic of abusive trauma.

Radiology case reports
2019

Classification and differential diagnosis of Wilson's disease.

Annals of translational medicine
2019

Ratiometric two-photon microscopy reveals attomolar copper buffering in normal and Menkes mutant cells.

Proceedings of the National Academy of Sciences of the United States of America
2019

Long surviving classical Menkes disease treated with weekly intravenous copper therapy.

Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS)
2019

Síntesis y uso de histidinato de cobre en niños con enfermedad de Menkes en México.

Gaceta medica de Mexico
2019

Fatal Exsanguination Following Rupture of an Iliac Artery Aneurysm in an Infant With Menkes Disease.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society
2019

ATP7A mutations in 66 Japanese patients with Menkes disease and carrier detection: A gene analysis.

Pediatrics international : official journal of the Japan Pediatric Society
2018

Biological role of copper as an essential trace element in the human organism.

Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti
2019

Urological Problems in Patients with Menkes Disease.

Journal of Korean medical science
2019

Copper complexes for biomedical applications: Structural insights, antioxidant activity and neuron compatibility.

Journal of inorganic biochemistry
2019

A systematic review and evidence-based guideline for diagnosis and treatment of Menkes disease.

Molecular genetics and metabolism
2018

Novel ATP7A gene mutation in a patient with Menkes disease.

The application of clinical genetics
2019

Epilepsy and Neurodegeneration: Clues in the Hair and Blood Vessels!

The Journal of pediatrics
2018

Cu2+ selective chelators relieve copper-induced oxidative stress in vivo.

Chemical science
2018

Predictable and precise template-free CRISPR editing of pathogenic variants.

Nature
2019

Chelating principles in Menkes and Wilson diseases: Choosing the right compounds in the right combinations at the right time.

Journal of inorganic biochemistry
2018

ATP7A and ATP7B copper transporters have distinct functions in the regulation of neuronal dopamine-β-hydroxylase.

The Journal of biological chemistry
2018

Emergent embolization of a ruptured splenic artery aneurysm complicating Menkes disease.

Radiology case reports
2018

Disulfiram enhanced delivery of orally administered copper into the central nervous system in Menkes disease mouse model.

Journal of inherited metabolic disease
2018

Menkes disease: Oral administration of glyoxal-bis(N(4)-methylthiosemicarbazonato)-copper(II) rescues the macular mouse.

Pediatric research
2018

Cerebrospinal Fluid-Directed rAAV9-rsATP7A Plus Subcutaneous Copper Histidinate Advance Survival and Outcomes in a Menkes Disease Mouse Model.

Molecular therapy. Methods &amp; clinical development
2019

Growing skull fracture at birth: a rare presentation of Menkes disease.

Archives of disease in childhood
2018

Neuroimaging findings in Menkes disease: a rare neurodegenerative disorder.

BMJ case reports
2019

Vacuolization in Myeloid and Erythroid Precursors in a Child with Menkes Disease.

Turkish journal of haematology : official journal of Turkish Society of Haematology
2017

Neuroimaging in Menkes Disease.

Journal of pediatric neurosciences
2018

Interaction between the AAA ATPase p97/VCP and a concealed UBX domain in the copper transporter ATP7A is associated with motor neuron degeneration.

The Journal of biological chemistry
2018

Multimodal LA-ICP-MS and nanoSIMS imaging enables copper mapping within photoreceptor megamitochondria in a zebrafish model of Menkes disease.

Metallomics : integrated biometal science
2018

Spontaneous retroperitoneal hemorrhage in Menkes disease: A rare case report.

Medicine
2018

Rare Disease Mechanisms Identified by Genealogical Proteomics of Copper Homeostasis Mutant Pedigrees.

Cell systems
2018

[Recent Trends of Trace Element Studies in Clinical Medicine in Japan].

Nihon eiseigaku zasshi. Japanese journal of hygiene
2017

Disorders of metal metabolism.

Translational science of rare diseases
2018

Wilson disease and related copper disorders.

Handbook of clinical neurology
2018

The Pivotal Role of Copper in Neurodegeneration: A New Strategy for the Therapy of Neurodegenerative Disorders.

Molecular pharmaceutics
2018

Tuning the Color Palette of Fluorescent Copper Sensors through Systematic Heteroatom Substitution at Rhodol Cores.

ACS chemical biology
2017

Menkes disease: A rare disorder.

JPMA. The Journal of the Pakistan Medical Association
2017

A novel nonsense ATP7A pathogenic variant in a family exhibiting a variable occipital horn syndrome phenotype.

Molecular genetics and metabolism reports
2017

How to use tests for disorders of copper metabolism.

Archives of disease in childhood. Education and practice edition
2017

Management of hyperplastic gastric polyp following upper gastrointestinal bleeding in infant with Menkes' disease.

World journal of gastrointestinal endoscopy
2017

A 37-year-old Menkes disease patient-Residual ATP7A activity and early copper administration as key factors in beneficial treatment.

Clinical genetics
2017

Evidence for widespread, severe brain copper deficiency in Alzheimer's dementia.

Metallomics : integrated biometal science
2017

Neuroimaging Changes in Menkes Disease, Part 1.

AJNR. American journal of neuroradiology
2017

Neuroimaging Changes in Menkes Disease, Part 2.

AJNR. American journal of neuroradiology
2017

Gene expression patterns in the progression of canine copper-associated chronic hepatitis.

PloS one
2017

13 novel putative mutations in ATP7A found in a cohort of 25 Italian families.

Metabolic brain disease
2017

[Analysis of clinical features and genetic mutations in a Chinese family affected with Menkes disease].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2017

Identification of novel ATP7A mutations and prenatal diagnosis in Chinese patients with Menkes disease.

Metabolic brain disease
2017

Characterization of ATP7A missense mutants suggests a correlation between intracellular trafficking and severity of Menkes disease.

Scientific reports
2017

Menkes Disease Mimicking Child Abuse.

Pediatric dermatology
2017

Menkes disease and response to copper histidine: An Indian case series.

Annals of Indian Academy of Neurology
2017

The role of insufficient copper in lipid synthesis and fatty-liver disease.

IUBMB life
Ver todos os 480 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Doença Menkes.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Doença Menkes

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Zycubo (copper histidinate), the first treatment for pediatric Menkes disease.
    Trends in pharmacological sciences· 2026· PMID 41820156mais citado
  2. Research Progress on Copper Metabolism, Cuprotosis, and Their Regulatory Mechanism in Tumor Diagnosis and Treatment.
    Cancer management and research· 2026· PMID 41869575mais citado
  3. Copper Homeostasis and Cuproptosis in Neurological Disorders.
    Drug design, development and therapy· 2026· PMID 41783572mais citado
  4. Patient Burden in the Treatment of Wilson Disease in the United States: An Analysis of Real-World Health Insurance Claims Data from the Komodo database.
    Advances in therapy· 2026· PMID 41718944mais citado
  5. Whole genome sequencing from dried blood spots for newborn screening of Menkes disease and 36 other actionable inherited neurometabolic disorders.
    Molecular genetics and metabolism· 2026· PMID 41687279mais citado
  6. Menkes Disease: Another Example of Progress in the Development of Pharmaceuticals for Rare Childhood Diseases, But Much Still Remains to Be Done.
    Clin Ther· 2026· PMID 41876279recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:565(Orphanet)
  2. OMIM OMIM:309400(OMIM)
  3. MONDO:0010651(MONDO)
  4. GARD:1521(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Artigo Wikipedia(Wikipedia)
  8. Q639203(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Doença Menkes
Compêndio · Raras BR

Doença Menkes

ORPHA:565 · MONDO:0010651
Prevalência
Unknown
Herança
X-linked recessive
CID-10
E83.0 · Distúrbios do metabolismo do cobre
CID-11
Ensaios
3 ativos
Início
Neonatal
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C0022716
EuropePMC
Wikidata
Wikipedia
Papers 10a
Evidência
🥇 Rev. sistemática
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades